Previous 10 | Next 10 |
BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesd...
2024-05-06 17:54:00 ET More on Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34 Cyclacel Pharmaceuticals receives $2.9M R&D tax credit Seeking Alpha...
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that it has closed its previously announced...
2024-05-02 08:33:18 ET More on pre-market losers & stocks. BioAtla, Inc. (BCAB) Q4 2023 Earnings Call Transcript Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript Cyclacel Pharmaceuticals GAAP EPS of -$6.23 misses by $0.34 Cyclacel Ph...
2024-05-01 08:34:29 ET More on pre-market losers & stocks. NRX Pharmaceuticals, Inc. (NRXP) Q4 2023 Earnings Call Transcript Cyclacel Pharmaceuticals, Inc. (CYCC) Q4 2023 Earnings Call Transcript Cemtrex, Inc. (CETX) Q1 2024 Earnings Call Transcript NRx P...
A look at the top 10 most actives in the United States Tilray Brands Inc. (TLRY) rose 39.5% to $2.47 on volume of 149,005,559 shares Tesla Inc. (TSLA) fell 5.6% to $183.28 on volume of 125,934,900 shares PROSHARES TRUST (SQQQ) rose 5.7% to $11.95 on volume of 124,394,426 shares Jaguar H...
2024-04-30 13:43:00 ET More on mid-day movers & stocks. Bakkt Holdings, Inc. (BKKT) Q4 2023 Earnings Call Transcript Bakkt Holdings, Inc. 2023 Q4 - Results - Earnings Call Presentation Cemtrex, Inc. (CETX) Q1 2024 Earnings Call Transcript Bakkt announces ...
2024-04-30 12:55:46 ET Usually when a publicly traded company announces some sort of equity offering, it can be viewed as a dilutive event, thus having a negative effect on the company’s price per share. Every now and then, however, a company will raise what seems to be the perfect a...
2024-04-30 10:01:07 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 19 out...
A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 38.0% to $0.0381 on volume of 59,468,925 shares Greenwave Technology Solutions Inc. (GWAV) rose 1.5% to $0.066 on volume of 45,683,331 shares Global Mofy Metaverse Limited (GMM) rose 68.4% to $1.5667 on volu...
News, Short Squeeze, Breakout and More Instantly...
Cyclacel Pharmaceuticals Inc. Company Name:
CYCC Stock Symbol:
NASDAQ Market:
Cyclacel Pharmaceuticals Inc. Website:
BERKELEY HEIGHTS, N.J., June 26, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the receipt of a notice from the European ...
- Novel CDK2/9 inhibitor fadraciclib induces anaphase catastrophe, a novel cancer-specific mechanism of action - BERKELEY HEIGHTS, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”...
- Clinical, PK and PD data from novel CDK2/9 inhibitor fadraciclib monotherapy studies support ongoing proof of concept study in patients with solid tumors and lymphoma - BERKELEY HEIGHTS, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;...